↓ Skip to main content

New Psychoactive Substances

Overview of attention for book
Cover of 'New Psychoactive Substances'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 83 Bioanalytical Methods for New Psychoactive Substances
  3. Altmetric Badge
    Chapter 102 Toxicokinetics of NPS: Update 2017
  4. Altmetric Badge
    Chapter 107 Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
  5. Altmetric Badge
    Chapter 110 Fatal Poisonings Associated with New Psychoactive Substances
  6. Altmetric Badge
    Chapter 111 Wastewater Analysis for Community-Wide Drugs Use Assessment
  7. Altmetric Badge
    Chapter 113 Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
  8. Altmetric Badge
    Chapter 124 Phencyclidine-Based New Psychoactive Substances
  9. Altmetric Badge
    Chapter 127 Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective
  10. Altmetric Badge
    Chapter 134 Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project
  11. Altmetric Badge
    Chapter 135 Patterns of Acute Toxicity Associated with New Psychoactive Substances
  12. Altmetric Badge
    Chapter 143 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
  13. Altmetric Badge
    Chapter 144 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
  14. Altmetric Badge
    Chapter 148 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
  15. Altmetric Badge
    Chapter 149 Synthetic Opioids
  16. Altmetric Badge
    Chapter 154 Designer Benzodiazepines: Another Class of New Psychoactive Substances
  17. Altmetric Badge
    Chapter 160 Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
  18. Altmetric Badge
    Chapter 177 Self-Experiments with Psychoactive Substances: A Historical Perspective
  19. Altmetric Badge
    Chapter 178 Neuropharmacology of Synthetic Cathinones
Attention for Chapter 160: Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

twitter
17 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
Chapter number 160
Book title
New Psychoactive Substances
Published in
Handbook of experimental pharmacology, September 2018
DOI 10.1007/164_2018_160
Pubmed ID
Book ISBNs
978-3-03-010560-0, 978-3-03-010561-7
Authors

Michael Evans-Brown, Roumen Sedefov, Evans-Brown, Michael, Sedefov, Roumen

Abstract

New psychoactive substances (NPS) are drugs that are not controlled by the United Nations international drug control conventions of 1961 and 1971 but that may pose similar threats to public health. Many of them are traded as "legal" replacements to controlled drugs such as cannabis, heroin, benzodiazepines, cocaine, amphetamines, and 3,4-methylenedioxymethamphetamine (MDMA). Driven by globalization, there has been a large increase in the availability and, subsequently, harms caused by these substances over the last decade in Europe. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is monitoring more than 670 NPS that have appeared on Europe's drug market in the last 20 years, of which almost 90% have appeared in the last decade. While some recent policy responses have been successful in reducing availability and sales of these substances in some settings - such as "legal highs" and "research chemicals" sold openly in the high street and online - and there are signs that growth in the market is slowing, new challenges have emerged. This includes monitoring a growing number of highly potent substances - including 179 synthetic cannabinoid receptor agonists and 28 fentanils - that can pose a high risk of life-threatening poisoning to users and can cause explosive outbreaks. This chapter briefly traces the origins of NPS, provides an overview of the situation in Europe, and discusses the work of the EMCDDA as part of a legal framework of early warning, risk assessment, and control measures that allows the European Union to rapidly detect, assess, and respond to public health and social threats caused by these substances.

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 21%
Student > Ph. D. Student 9 19%
Student > Bachelor 7 15%
Researcher 5 10%
Student > Doctoral Student 4 8%
Other 4 8%
Unknown 9 19%
Readers by discipline Count As %
Medicine and Dentistry 10 21%
Pharmacology, Toxicology and Pharmaceutical Science 8 17%
Chemistry 4 8%
Social Sciences 4 8%
Nursing and Health Professions 3 6%
Other 8 17%
Unknown 11 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2022.
All research outputs
#2,219,244
of 22,287,733 outputs
Outputs from Handbook of experimental pharmacology
#79
of 640 outputs
Outputs of similar age
#45,700
of 298,526 outputs
Outputs of similar age from Handbook of experimental pharmacology
#1
of 1 outputs
Altmetric has tracked 22,287,733 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 640 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them